ERIC O'BRIEN OD
Prescription History 1386931921
Optometrist in West Burlington, IA

Active since July 04, 2011PECOS EnrolledAccepts Medicare Assignment
324 W AGENCY RD, WEST BURLINGTON, IA 52655(319) 753-3115 Get Directions

NPPES record last updated: August 5, 2019. Verified against the NPPES registry weekly; last sync: October 18, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for ERIC O'BRIEN OD, an active Optometrist specialist practicing in West Burlington, IA. Our medical registry currently tracks 8 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 536 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 211 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

8
Medications
536
Total Claims
1,146
30-Day Fills
Latanoprost
Most Prescribed · 211 claims
View details
8 medications · 2024 Medicare Part D
Medicare Part D medications prescribed by ERIC O'BRIEN OD in 2024, with prescription volumes, average cost per fill, and IA state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other IA PrescribersVs. IA Avg

About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾

It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA.

In 2024, this provider wrote 211 Medicare prescriptions for Latanoprost, about 1.7 times the volume of the typical Iowa prescriber of this medication (125). Medicare paid an average of $12.14 per fill, versus $9.98 statewide.

How often this provider prescribes it

This provider
211
IA average
125.0

This provider prescribes this medication more often than the average IA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$12.14
IA average
$9.98

Gross Part D cost per fill; not the patient's out-of-pocket price.

519.7
30-Day Fills
standardized to 30-day supplies
15,442
Days of Medication
total across all patients in 2024

About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾

Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

In 2024, this provider wrote 112 Medicare prescriptions for Brimonidine Tartrate, about 2.3 times the volume of the typical Iowa prescriber of this medication (48.9). Medicare paid an average of $11.38 per fill, versus $31.82 statewide.

How often this provider prescribes it

This provider
112
IA average
48.9

This provider prescribes this medication more often than the average IA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$11.38
IA average
$31.82

This provider's average cost per fill is below the IA average for this medication.

221.7
30-Day Fills
standardized to 30-day supplies
6,424
Days of Medication
total across all patients in 2024

About Restasis: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾

They work by increasing the amount of tears you make. A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed).

In 2024, this provider wrote 79 Medicare prescriptions for Restasis, about 2.5 times the volume of the typical Iowa prescriber of this medication (31.7). Medicare paid an average of $1,120.94 per fill, versus $870.13 statewide.

How often this provider prescribes it

This provider
79
IA average
31.7

This provider prescribes this medication more often than the average IA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,120.94
IA average
$870.13

Gross Part D cost per fill; not the patient's out-of-pocket price.

149
30-Day Fills
standardized to 30-day supplies
4,140
Days of Medication
total across all patients in 2024

About Azelastine Hcl: This medication is used to relieve nasal symptoms such as runny/itching/stuffy nose, sneezing, and post-nasal drip caused by allergies or other conditions. Show more ▾

Azelastine belongs to a class of drugs known as antihistamines. It works by blocking certain natural substances called histamines that are responsible for nasal symptoms. Azeptin is azelastine hydrochloride; structure; eye drop formulation effective in relieving symptoms of allergic conjunctivitis; do not confuse with 5-loxin which is an extract of Boswellia.

In 2024, this provider wrote 43 Medicare prescriptions for Azelastine Hcl, about 1.3 times the volume of the typical Iowa prescriber of this medication (33.4). Medicare paid an average of $27.95 per fill, versus $25.93 statewide.

How often this provider prescribes it

This provider
43
IA average
33.4

This provider prescribes this medication more often than the average IA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$27.95
IA average
$25.93

Gross Part D cost per fill; not the patient's out-of-pocket price.

46.3
30-Day Fills
standardized to 30-day supplies
1,310
Days of Medication
total across all patients in 2024

About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾

Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors.

In 2024, this provider wrote 35 Medicare prescriptions for Dorzolamide-Timolol, about half the volume of the typical Iowa prescriber of this medication (68.6). Medicare paid an average of $13.51 per fill, versus $16.85 statewide.

How often this provider prescribes it

This provider
35
IA average
68.6

This provider prescribes this medication less often than the average IA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$13.51
IA average
$16.85

This provider's average cost per fill is below the IA average for this medication.

91
30-Day Fills
standardized to 30-day supplies
2,730
Days of Medication
total across all patients in 2024

About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾

Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

In 2024, this provider wrote 34 Medicare prescriptions for Lumigan, about 70% of the volume of the typical Iowa prescriber of this medication (48.8). Medicare paid an average of $620.57 per fill, versus $439.65 statewide.

How often this provider prescribes it

This provider
34
IA average
48.8

This provider prescribes this medication less often than the average IA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$620.57
IA average
$439.65

Gross Part D cost per fill; not the patient's out-of-pocket price.

73.9
30-Day Fills
standardized to 30-day supplies
2,169
Days of Medication
total across all patients in 2024

About Neomycin-Polymyxin-Dexameth: This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. Show more ▾

This product contains neomycin and polymyxin, antibiotics that work by stopping the growth of bacteria. It also contains dexamethasone, an anti-inflammatory corticosteroid that works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (such as infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

In 2024, this provider wrote 11 Medicare prescriptions for Neomycin-Polymyxin-Dexameth, about a third of the volume of the typical Iowa prescriber of this medication (33.1). Medicare paid an average of $9.04 per fill, versus $10.69 statewide.

How often this provider prescribes it

This provider
11
IA average
33.1

This provider prescribes this medication less often than the average IA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$9.04
IA average
$10.69

This provider's average cost per fill is below the IA average for this medication.

11
30-Day Fills
standardized to 30-day supplies
177
Days of Medication
total across all patients in 2024

About Xiidra: This medication is used to treat dry eye disease. Show more ▾

An LFA-1 (LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1) antagonist that is used in the treatment of DRY EYE SYNDROMES.

In 2024, this provider wrote 11 Medicare prescriptions for Xiidra, about 61% of the volume of the typical Iowa prescriber of this medication (18.2). Medicare paid an average of $2,090.60 per fill, versus $922.46 statewide.

How often this provider prescribes it

This provider
11
IA average
18.2

This provider prescribes this medication less often than the average IA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$2,090.60
IA average
$922.46

Gross Part D cost per fill; not the patient's out-of-pocket price.

33
30-Day Fills
standardized to 30-day supplies
990
Days of Medication
total across all patients in 2024
No medications match the current filters.
= the 5 medications this provider prescribes most.▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average IA prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the IA average cost per fill.

About this data. The prescription history for ERIC O'BRIEN OD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this West Burlington, IA practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among IA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.